LNTH Lantheus Holdings Inc

$67.16

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 1/6/2026

About Lantheus Holdings Inc

Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.

Website: https://www.lantheus.com

Sector
LIFE SCIENCES
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1521036
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA, US
Valuation
Market Cap
$6.95B
P/E Ratio
23.24
PEG Ratio
0.61
Price to Book
6.39
Performance
EPS
$4.36
Dividend Yield
Profit Margin
20.40%
ROE
32.80%
Technicals
50D MA
$94.86
200D MA
$98.47
52W High
$126.89
52W Low
$62.59
Fundamentals
Shares Outstanding
69M
Target Price
$134.38
Beta
0.20

LNTH EPS Estimates vs Actual

Estimated
Actual

LNTH News & Sentiment

Dec 30, 2025 • MarketBeat SOMEWHAT-BULLISH
Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Average Recommendation of "Moderate Buy" by Brokerages
Lantheus Holdings, Inc. (NASDAQ:LNTH) has received a "Moderate Buy" consensus rating from eight brokerages, with an average one-year price target of $78.00. Institutional investors significantly own 99.06% of the stock, with several funds increasing their stakes. The company's shares are currently trading around $67.34, with a market capitalization of $4.47 billion.
Dec 29, 2025 • PHL17.com BEARISH
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Lantheus Holdings, Inc. (NASDAQ:LNTH) regarding potential corporate wrongdoing. The firm is encouraging investors who purchased Lantheus securities prior to November 6, 2024, and continue to hold them, to connect and assist with the investigation. The firm operates on a contingency fee basis, aiming to restore investor capital and ensure corporate accountability.
Dec 29, 2025 • WRIC ABC 8News SOMEWHAT-BEARISH
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Lantheus Holdings, Inc. (LNTH) for alleged corporate wrongdoing, specifically focusing on investors who held securities prior to November 6, 2024. The firm encourages affected investors to connect through their website to assist in the investigation, operating on a contingency fee basis. This investigation aims to recover investor capital and ensure corporate accountability.
Dec 28, 2025 • DC News Now SOMEWHAT-BEARISH
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential corporate wrongdoing by Lantheus Holdings, Inc. (LNTH). The firm encourages investors who purchased Lantheus securities before November 6, 2024, and still hold them, to contact them to assist with the investigation. The firm operates on a contingency fee basis, aiming to recover investor capital and ensure corporate accountability.
Dec 28, 2025 • MarketBeat NEUTRAL
Voya Investment Management LLC Has $2.41 Million Stock Position in Lantheus Holdings, Inc. $LNTH
Voya Investment Management LLC reduced its stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) by 34.3% in the third quarter of 2025, now holding 46,956 shares valued at approximately $2.41 million. Despite this reduction, other institutional investors increased their positions, with institutional ownership of the company's stock at 99.06%. Lantheus, a medical equipment provider, has a market cap of $4.42 billion and a "Moderate Buy" consensus rating from analysts with an average target price of $78.00.
Dec 28, 2025 • MarketBeat SOMEWHAT-BULLISH
Pacer Advisors Inc. Boosts Stock Position in Lantheus Holdings, Inc. $LNTH
Pacer Advisors Inc. significantly increased its stake in Lantheus Holdings, Inc. by 21.3% in Q3, acquiring an additional 74,272 shares to reach a total of 422,180 shares valued at approximately $21.65 million. This move is part of a broader trend, with several other institutional investors also raising their positions, resulting in 99.06% institutional ownership of the company. Lantheus, trading under NASDAQ:LNTH, has a market cap of $4.42 billion and is rated a “Moderate Buy” by analysts with an average price target of $78.00.
Sentiment Snapshot

Average Sentiment Score:

-0.081
50 articles with scored sentiment

Overall Sentiment:

Neutral

LNTH Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
-0.1 Surprise
  • Reported EPS: $1.57
  • Estimate: $1.67
  • Whisper:
  • Surprise %: -6.0%
May 07, 2025
Mar 31, 2025 (Pre market)
-0.12 Surprise
  • Reported EPS: $1.53
  • Estimate: $1.65
  • Whisper:
  • Surprise %: -7.5%
Feb 26, 2025
Dec 31, 2024 (Pre market)
0.05 Surprise
  • Reported EPS: $1.59
  • Estimate: $1.54
  • Whisper:
  • Surprise %: 3.0%
Nov 06, 2024
Sep 30, 2024 (Pre market)
0.14 Surprise
  • Reported EPS: $1.70
  • Estimate: $1.56
  • Whisper:
  • Surprise %: 9.0%
Jul 31, 2024
Jun 30, 2024 (Pre market)
-0.03 Surprise
  • Reported EPS: $1.80
  • Estimate: $1.83
  • Whisper:
  • Surprise %: -1.6%
May 02, 2024
Mar 31, 2024 (Pre market)
0.15 Surprise
  • Reported EPS: $1.69
  • Estimate: $1.54
  • Whisper:
  • Surprise %: 9.7%
Feb 22, 2024
Dec 31, 2023 (Pre market)
0.3 Surprise
  • Reported EPS: $1.75
  • Estimate: $1.45
  • Whisper:
  • Surprise %: 20.7%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.15 Surprise
  • Reported EPS: $1.47
  • Estimate: $1.32
  • Whisper:
  • Surprise %: 11.4%
Aug 03, 2023
Jun 30, 2023 (Pre market)
0.23 Surprise
  • Reported EPS: $1.54
  • Estimate: $1.31
  • Whisper:
  • Surprise %: 17.6%

Financials